Cardiotoxicity from Immunotherapy: Can Advanced Cardiac Imaging Meet the Challenge?

Advanced Cardiac Imaging Among Patients with Cardiovascular Complications From Cancer ImmunotherapyПодробнее

Cardiotoxicity of Cancer Therapies: A Review for the Oncology Provider - B. C. Jensen - 20211215Подробнее

Drs. Moslehi & Johnson discuss Cardiac irAEs updates from #AHA21: https://bit.ly/31LJaP3Подробнее

JACC: CardioOncology Video Case Presentation | Early Immune Checkpoint Inhibitor CardiotoxicityПодробнее

Immune Checkpoint Inhibitor CardiotoxicityПодробнее

CMR in Cardio-Oncology, Dr. Juan Lopez-MatteiПодробнее

Dr. Javid Moslehi: Why cardiologists must care about cancer immunotherapyПодробнее

Immune Checkpoint Inhibitor CardiotoxicityПодробнее

CV Impact of Immune Checkpoint Inhibitor CardiotoxicityПодробнее

Remaining challenges in reducing or preventing cardiotoxicity in patients receiving immunotherapyПодробнее

The challenges with monitoring patients with lymphoma for cardiotoxicityПодробнее

Cardio-oncology What is the Big Picture, What Drugs to Use, Tests to FollowПодробнее

Sponsored Symposium | Changing the Beat in Cardiac Care with Advanced CT TechnologiesПодробнее

Cardiac Magnetic Resonance in Multi-Modality Cardio-Oncology Imaging: The Present and the FutureПодробнее

Challenges with BTKi cardiotoxicity: what can be done to optimize long-term cardiac outcomes?Подробнее

377. CardioOncology:  Multi-modality Imaging in Cardio-Oncology with Dr. Nausheen AkhterПодробнее

How should we deal with cardiotoxicity caused by immunotherapy?Подробнее

Risk factors for cardiotoxic events in patients treated with immune checkpoint inhibitorsПодробнее

Immune checkpoint inhibitors: recent progress and potential biomarkers - 3ii PD-L1 OverexpressionПодробнее